Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Income (Loss) Before Income Taxes |
Income (loss) from continuing operations before income taxes consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | (Millions) | | 2025 | | 2024 | | 2023 | | United States | | $ | 1,870 | | | $ | 2,300 | | | $ | (13,272) | | | International | | 2,343 | | | 2,519 | | | 2,001 | | | Total | | $ | 4,213 | | | $ | 4,819 | | | $ | (11,271) | |
As of December 31, 2025, the Company's tax effected operating losses, capital losses, and tax credit carryovers before limitation impacts and valuation allowances were approximately: | | | | | | | | | | | | | | | | Jurisdiction | | (in millions) | | Carryover period | | Federal | | $ | 290 | | | 4 years to 20 years | | State | | 120 | | | 5 years to indefinite | | International | | 75 | | | 7 years to indefinite |
|
| Schedule of Provision (Benefit) for Income Taxes |
Provision (benefit) for income taxes consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | (Millions) | | 2025 | | 2024 | | 2023 | | Current | | | | | | | | Federal | | $ | (11) | | | $ | (75) | | | $ | 302 | | | State | | (1) | | | (6) | | | 38 | | | International | | 597 | | | 583 | | | 494 | | | Deferred | | | | | | | | Federal | | 307 | | | 328 | | | (3,084) | | | State | | 21 | | | 1 | | | (495) | | | International | | 90 | | | (27) | | | (122) | | | Total | | $ | 1,003 | | | $ | 804 | | | $ | (2,867) | |
|
| Schedule of Cash Income Tax Payments |
Cash income tax payments, net of refunds, consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | (Millions) | | 2025 | | 2024 | | 2023 | | Federal | | $ | 211 | | | | | | | State | | 28 | | | | | | International | | 561 | | | | | | China | | 134 | | | | | India | | 44 | | | | | | Korea | | 44 | | | | | | Other international | | 339 | | | | | | Total | | $ | 800 | | | $ | 852 | | | $ | 1,384 | |
|
| Schedule of Effective Income Tax Rate |
A reconciliation of the U.S. federal statutory income tax rate to 3M's worldwide effective income tax rate is provided below: | | | | | | | | | | | | | | | | | 2025 | | (Millions) | | Amount | | Percent | | U.S. federal statutory tax rate | | $ | 885 | | | 21.0 | % | State and local income taxes, net of federal income tax effect(a) | | 26 | | | 0.6 | | | Foreign tax effects | | 212 | | | 5.0 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Effect of cross-border tax laws | | | | | | Global intangible low-taxed income (net of foreign tax credits) | | 100 | | | 2.4 | | | | | | | | Other | | (71) | | | (1.7) | | | Tax credits | | (44) | | | (1.0) | | | Changes in valuation allowances | | (87) | | | (2.1) | | | Nontaxable or nondeductible items | | 32 | | | 0.8 | | | Changes in unrecognized tax benefits | | (50) | | | (1.2) | | | Effective worldwide tax rate | | $ | 1,003 | | | 23.8 | % |
(a) State taxes in California, Florida, Iowa, Massachusetts, New York, Virginia and Wisconsin made up the majority (greater than 50 percent) of this category. | | | | | | | | | | | | | | | | | | | | 2024 | | 2023(b) | | Statutory U.S. tax rate | | 21.0 | % | | 21.0 | % | | State income taxes - net of federal benefit | | 0.6 | | | 3.2 | | International income taxes - net (c) | | 2.1 | | | 0.6 | | | Global intangible low taxed income (GILTI) | | 0.6 | | | (0.3) | | | Foreign derived intangible income (FDII) | | (0.3) | | | 0.6 | | | U.S. research and development credit | | (0.7) | | | 0.4 | | | Reserves for tax contingencies | | 0.6 | | | (0.4) | | | Employee share-based payments | | 0.4 | | | — | | | Change in valuation allowance on Solventum ownership | | (7.7) | | | — | | | All other - net | | 0.1 | | | 0.3 | | | Effective worldwide tax rate | | 16.7 | % | | 25.4 | % |
(b) A positive rate reconciliation percent for the year ended 2023 is a tax benefit on a pretax loss. (c) International income taxes include tax expense associated with international earnings no longer considered permanently reinvested. 3M estimates that year-on-year foreign currency transaction effects, impacted pre-tax income (loss) from continuing operations approximately as follows. These estimates include transaction gains and losses, including derivative instruments designed to reduce foreign currency exchange rate risks. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (Millions) | | | | | | | | | | 2025 | | 2024 | | 2023 | Year-on-year change in pre-tax income (loss) from foreign currency transactions | | | | | | | | | | $ | (59) | | | $ | (34) | | | $ | 40 | |
|
| Schedule of Unrecognized Tax Benefits |
A reconciliation of the beginning and ending amount of gross UTB is as follows: | | | | | | | | | | | | | | | | | | | | | | (Millions) | | 2025 | | 2024 | | 2023 | | Gross UTB balance at beginning of period | | $ | 574 | | | $ | 590 | | | $ | 632 | | | Additions based on tax positions related to the current year | | 46 | | | 13 | | | 11 | | | Additions for tax positions of prior years | | 64 | | | 57 | | | 63 | | | Reductions for tax positions of prior years | | (87) | | | (16) | | | (42) | | | Settlements | | (45) | | | (17) | | | (33) | | | Reductions due to lapse of applicable statute of limitations | | (49) | | | (36) | | | (42) | | | Foreign currency translation | | 13 | | | (17) | | | 1 | | Gross UTB balance at end of period | | $ | 516 | | | $ | 574 | | | $ | 590 | | Gross interest and penalties (benefits) recognized in the consolidated statement of income (loss) (d) | | $ | 6 | | | $ | 25 | | | $ | 83 | | Gross accrued interest and penalties in the consolidated balance sheet at end of period | | $ | 195 | | | $ | 207 | | | $ | 183 | |
(d) The Company recognizes interest and penalties accrued related to UTB in tax expense. The amount of interest and penalties recognized may be an expense or benefit due to new or remeasured UTB accruals.
|
| Schedule of Income Tax Holiday |
As a result of certain employment commitments and capital investments made by 3M, income from certain foreign operations in the following countries is subject to reduced tax rates or, in some cases, is exempt from tax for years through the following: Singapore (2025), Switzerland (2026), China (2028) and Brazil (2034). The continuing income tax benefits attributable to the tax status of these subsidiaries are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | (Millions, except per share) | | 2025 | | 2024 | | 2023 | Income tax benefits attributable to reduced tax rates or exemptions in foreign locations | | $ | 58 | | | $ | 87 | | | $ | 100 | | | Per diluted share impact of reduced tax rates or exemptions in foreign locations | | $ | 0.11 | | | $ | 0.16 | | | $ | 0.18 | |
|
| Schedule of Components of Deferred Tax Assets and Liabilities |
Components of deferred tax assets and (liabilities) are comprised of the following: | | | | | | | | | | | | | | | | (Millions) | | December 31, 2025 | | December 31, 2024 | | Deferred tax assets: | | | | | | | | | | | Employee benefit costs | | $ | 250 | | | $ | 241 | | | Product and other claims | | 2,541 | | | 3,154 | | | Investments | | 175 | | | 333 | | | Miscellaneous accruals | | 220 | | | 143 | | | | | | | | Stock-based compensation | | 222 | | | 267 | | | | | | | | Net operating/capital loss/tax credit carryforwards | | 275 | | | 130 | | | Foreign tax credits | | 210 | | | 143 | | | Research and experimentation capitalization | | 820 | | | 720 | | | Lease liabilities | | 137 | | | 150 | | | Intangible amortization | | 176 | | | 104 | | | | | | | | Other | | 229 | | | 70 | | | Gross deferred tax assets | | 5,255 | | | 5,455 | | Valuation allowance(e) | | (1,052) | | | (1,061) | | | Total deferred tax assets | | $ | 4,203 | | | $ | 4,394 | | | | | | | | Deferred tax liabilities: | | | | | | | | | | | Depreciation | | $ | (403) | | | $ | (263) | | | | | | | | | | | | | Right-of-use asset | | (136) | | | (151) | | | Other | | (256) | | | (188) | | | Total deferred tax liabilities | | $ | (795) | | | $ | (602) | | | | | | | Net deferred tax assets(f) | | $ | 3,408 | | | $ | 3,792 | |
(e) The company has provided a valuation allowance against certain of these deferred tax assets, including the difference in basis of the retained ownership interest in Solventum, based on management’s determination that it is more-likely-than-not that the tax benefits related to these assets will not be realized. (f) As of December 31, 2025 and December 31, 2024, these amounts include $3,826 million and $4,146 million, respectively, of deferred tax assets reported in Other Assets on 3M’s consolidated balance sheet, and $418 million and $354 million, respectively, of deferred tax liabilities reported in Other Liabilities on 3M’s consolidated balance sheet.
|